The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,296.00
Bid: 12,322.00
Ask: 12,324.00
Change: -108.00 (-0.87%)
Spread: 2.00 (0.016%)
Open: 12,334.00
High: 12,362.00
Low: 12,250.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Earnings come in mixed as investors watch US data, Fed

Thu, 31st Jul 2014 12:04

- Shell, BG Group and Intu lead the risers- Weir, Schroders and Lloyds fall- Afren drops after suspending directors- US data and Fed keep investors cautioustechMARK 2,763.54 -0.57%FTSE 100 6,763.04 -0.15%FTSE 250 15,495.73 -0.86%London stocks were trading in the red for a second straight day on Thursday as investors gave a mixed reaction to a wave of blue-chip corporate earnings and showed their nerves amid policy tightening speculation in the States. Results from Shell, BG Group, Intu Properties impressed the market in morning trade, offset by falls from Weir, Schroders and Lloyds. Meanwhile, the share price of oil explorer Afren plummeted after the company suspended two directors.The FTSE 100 was down 0.15% at 6,763 around midday.The Federal Reserve decided on Wednesday night to taper stimulus by $10bn a month for the sixth straight time, putting the central bank on course to end its quantitative easing programme in October.However, with the end of monetary stimulus now fast approaching, Wednesday's better-than-expected US growth figures - economy expanded by 4% in second quarter - traders are now concerned that policymakers could be tempted to raise interest rates sooner than expected.Jasper Lawler, a market analyst at CMC Markets, said that Fed Chair Janet Yellen had aimed to be "dovish while demonstrating a gradual hawkish shift" in the Fed's statement on Wednesday. However, with growth above expectations and inflation running at the target 2% amid a strengthening labour market, he said the "markets didn't really buy the Fed's attempt at dovishness"."After growth and inflation, Friday's non-farm payrolls will be the third point in the rate hike 'triangle', another 200k+ report and unemployment below 6% means the Fed really have no excuses not to tighten," he said.The consensus forecast for the all-important 'official' US employment report is for a 231,000 gain in non-farm payrolls in July, down from an impressive 288,000 in June. The unemployment rate is expected to remain unchanged after falling to 6.1%, its lowest since September 2008.As for Thursday's session, the focus will be on weekly US initial jobless claims, which are predicted to have risen to 300,000 from a post-recession low of 284,000 the previous week.Earnings come in mixedOil major Royal Dutch Shell impressed with shares rising strongly after saying earnings more than doubled in the second quarter to $5.1bn, even when including a $1bn net charge due to impairments. Natural gas group BG Group was also higher as it lifted its interim by a tenth after a strong second quarter led to a 9% increase in earnings per share in the first half.Intu Properties was in favour after the real estate firm said higher rental income helped to lift underlying earnings as the letting market showed "encouraging signs of improvement".Heading the other way banking group Lloyds which underwhelmed after saying that underlying profits improved by 32% to £3.82bn in the first half of the year, ahead of the £3.6bn consensus forecast. This was achieved despite a 2.2% fall in total underlying income to £9.25bn.Engineer Weir was in the red after reporting that profits slid 6% in the first half, reflecting adverse foreign exchange currency exchange rate movements and challenging conditions in the mining industry. Even though it unexpectedly hiked its half-year dividend 50% to 24p, shares in asset manager Schroders slipped after it sounded a note of caution about the retail investor market. Meanwhile, telecoms group BT and drinks giant Diageo both rose after their results, while engine maker Rolls-Royce and drugs group AstraZeneca underwhelmed.On the FTSE 250, Afren shares plummeted after the company said that it has suspended its chief executive officer and chief operating officer as an investigation found "the receipt of unauthorised payments potentially for the benefit of the CEO and COO".FTSE 100 - RisersRoyal Dutch Shell 'B' (RDSB) 2,583.50p +3.80%Royal Dutch Shell 'A' (RDSA) 2,454.00p +3.00%Intu Properties (INTU) 328.60p +2.59%BG Group (BG.) 1,203.00p +1.91%BT Group (BT.A) 390.80p +0.75%GlaxoSmithKline (GSK) 1,435.00p +0.70%BP (BP.) 484.95p +0.66%Diageo (DGE) 1,799.00p +0.56%Antofagasta (ANTO) 820.50p +0.55%easyJet (EZJ) 1,297.00p +0.54%FTSE 100 - FallersWeir Group (WEIR) 2,556.00p -4.20%Schroders (SDR) 2,417.00p -3.28%St James's Place (STJ) 732.00p -3.05%Lloyds Banking Group (LLOY) 74.40p -2.63%Barratt Developments (BDEV) 348.40p -2.60%GKN (GKN) 342.90p -2.39%3i Group (III) 377.70p -2.38%Aggreko (AGK) 1,729.00p -2.26%Sports Direct International (SPD) 670.00p -2.12%Petrofac Ltd. (PFC) 1,089.00p -2.07%FTSE 250 - RisersLaird (LRD) 285.80p +6.76%Hochschild Mining (HOC) 163.40p +2.90%Bodycote (BOY) 710.50p +2.53%Domino's Pizza Group (DOM) 547.00p +1.86%Countrywide (CWD) 524.50p +1.84%Barr (A.G.) (BAG) 661.00p +1.69%Workspace Group (WKP) 607.50p +1.59%Inchcape (INCH) 647.50p +1.57%Thomas Cook Group (TCG) 123.20p +1.07%Rightmove (RMV) 2,258.00p +1.07%FTSE 250 - FallersAfren (AFR) 111.50p -25.07%IP Group (IPO) 181.30p -4.58%Man Group (EMG) 120.50p -4.44%Pace (PIC) 322.60p -4.39%Supergroup (SGP) 1,019.00p -4.23%Bank of Georgia Holdings (BGEO) 2,417.00p -3.09%Homeserve (HSV) 295.30p -2.93%JD Sports Fashion (JD.) 380.10p -2.91%Jupiter Fund Management (JUP) 382.70p -2.87%Ocado Group (OCDO) 333.40p -2.71%BC
More News
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more
19 Feb 2024 08:36

TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data

(Alliance News) - AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.